| Jun 2008 | 2007 | 2006 | 2005 | 2004 | |||
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 0.02 | 0.01 | 0.10 | 0.00 | 0.00 | ||
| Depreciation & Amort ($Mil): | 8.97 | 8.97 | 8.51 | 7.39 | 7.17 | ||
| Operating Income ($Mil): | -309.56 | -307.35 | -233.69 | -118.12 | -77.14 | ||
| Net Income ($Mil): | -299.31 | -293.19 | -230.54 | -114.33 | -75.99 | ||
| Earnings Per Share ($): | -3.23 | -3.66 | -4.52 | -2.87 | -3.80 | ||
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | |||
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 187.70 | 378.71 | 449.54 | 149.87 | 95.88 | ||
| Current Liabilities ($Mil): | 61.95 | 67.55 | 44.95 | 21.36 | 13.04 | ||
| Long Term Debt ($Mil): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Shares Outstanding (000): | 101430 | 100920 | 69900 | 50230 | 32720 | 0 | 0 |
| Common Equity ($Mil): | 225.28 | 364.10 | 383.48 | 206.97 | 150.36 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | |||
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -1496550.00 | -2931900.00 | -230540.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity (%): | -112.20 | -80.52 | -60.12 | -55.24 | -50.54 | 0.00 | 0.00 |
| Return on Assets (%): | -68 | -53.95 | -42.71 | -50.06 | -46.48 | 0.00 | 0.00 |
| P/E Ratio: | 0 | -3.33 | -4.04 | -4.33 | -17.79 | 0.00 | 0.00 |
| Price/Book: | 1 | 3.38 | 3.32 | 3.02 | 14.71 | NaN | NaN |
| Debt Equity: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage: | 0.00 | 0.00 | -132.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value ($): | 2.22 | 3.61 | 5.49 | 4.12 | 4.60 | 0.00 | 0.00 |
| Price/Sales: | 49248.96 | 15163.79 | 12749.76 | N/C | N/C | NaN | NaN |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |


| AMGEN | -15.10 | 48.58 | |
| GILEAD SCIENCES | -26.60 | 37.47 | |
| GENENTECH INC | -9.90 | 73.00 | |
| CELGENE CP | -26.70 | 54.52 | |
| BIOGEN IDEC INC | -34.90 | 42.78 |
